BioSpace News Archive

Clinical Laserthermia Systems AB, announced the American Medical Association has approved its application and issued a Category level III Current Procedural Terminology reimbursement code for “transperineal focal laser ablation of malignant prostate tissue with ultrasoundguidance.” The new code is expected to be formally finalized and active from July 1, 2021.

On Tuesday November 10, at 16.00 CET, IRRAS will host a conference call and an online presentation of its Q3 2020 interim report.

In its virtual booth at the 2020 Radiological Society of North America annual meeting, international medical imaging IT and cybersecurity company Sectra will showcase its complete enterprise imaging offering, which empowers radiologists to accomplish more.

In connection with the publication of the Interim Report for Q3 2020, an updated guiding was shared for the full year 2020.

BiomX Inc. (NYSE American: PHGE), a clinical stage company developing natural and engineered phage therapies that target specific pathogenic bacteria, today announced that the first subject has been dosed in a Phase 1a study of BX002, a phage therapy candidate for the treatment of inflammatory bowel disease (IBD).

Evotec SE announced that its management will be presenting at and attending the following upcoming conferences until the end of 2020:

Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (TSX:TBP)(OTCQB:TBPMF), a leader in cannabinoid-derived drug discovery and development, today provided an update on the potential market of its new drug, ARDS-003

Protara Therapeutics, Inc. announced the grants of inducement non-qualified stock options to purchase an aggregate of 5,200 shares of common stock to two new employees.

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, and Veeva Systems (NYSE: VEEV), today announced a strategic partnership to augment the build of Axsome’s Digital-Centric Commercialization (DCC™) platform.

Bio-Techne Corporation (NASDAQ: TECH) today announced that Chuck Kummeth, President and Chief Executive Officer, will present at the Stifel 2020 Virtual Healthcare Conference on Monday, November 16, 2020 at 1:20 p.m. EST